Inside the hiring process for biotech CEOs

Clinical OMICsAI Foundation Model Maps Tumor Mutations to Predict Cancer Therapy Response

BioPharma DiveCardio drugmaker Kardigan plans to go public

BioPharma DiveKailera’s three-pronged obesity shot shows promise in early trial

BioPharma DiveApogee eczema drugs gets Blackstone backing, heads to Phase 3

Endpoints NewsAstraZeneca's breast cancer PDUFA delayed; Arrowhead aims at same obesity target as Wave

Endpoints NewsApogee secures Blackstone capital to move Dupixent rival into Phase 3

Clinical OMICsPrecancerous Adenomas Alter Gut Microbiome for Long Period

FierceBiotechD&D sees fibrosis improvements, MASH resolution after rolling dice on GLP-1 drug

FierceBiotechInsulet issues voluntary correction for Omnipod devices in leaky insulin fault

Endpoints NewsWuXi Bio signs deal to manufacture Viridian's thyroid eye disease drug

Endpoints News#ASCO26: Cancer immunotherapy's magic bullet era is fading. Here's what's next

Endpoints NewsBiopharma Sentiment Index | Q2 2026